Congress of the European Society of
Clinical Microbiology and Infectious Diseases
This abstract collection features the top submissions recognised for their exceptional scientific quality, innovation, and impact to be presented during oral or poster presentation at ESCMID Global 2025. Selected through a rigorous peer-review process, these abstracts and posters represent groundbreaking advancements and cutting-edge discoveries from experts worldwide. Explore the latest research shaping the future of infectious disease prevention, diagnosis, and treatment.
|
Presenter |
Abstract Title |
Presenter |
Session Type |
Time |
Hall |
|---|---|---|---|---|---|
|
Prieto Martín Gil, Sonia |
Comparative immune responses to homologous and heterologous SARS-CoV-2 vaccination using DNA and protein platforms |
EF003 |
ePoster Flash |
8:30-9:30 |
Arena 1 |
|
Bischoff, Peter |
WHO global survey on infection prevention and control minimum requirements: laying the foundation for 2030 global targets |
EF014 |
ePoster Flash |
11:00-12:00 |
Arena 2 |
|
Dudareva, Maria |
Short or long antibiotic regimes in orthopaedics: the SOLARIO multicentre randomised controlled trial |
EF015 |
ePoster Flash |
11:00-12:00 |
Arena 3 |
|
Kieffer, Nicolas |
Gfa, a novel integron-born fosfomycin resistance mechanism |
EF024 |
ePoster Flash |
13:30-14:30 |
Arena 4 |
|
Wang, Xiaojuan |
Regulons of RA, RarA and SoxS mediated tigecycline resistance and oxidative stress ong in vitro tigecycline resistant evolution trajectory of Klebsiella pneumoniae |
EF024 |
ePoster Flash |
13:30-14:30 |
Arena 4 |
|
Kovanda, Laura |
Enhancing isavuconazole pharmacokinetics: a comprehensive population (PPK) model from three Phase 3 trials and covariate exploration |
EF006 |
ePoster Flash |
9:30-10:30 |
Arena 4 |
|
Carretto, Edoardo |
In vivo cefiderocol resistance due to cirA modification during treatment |
OS010 |
1-Hour Oral |
11:00-12:00 |
Hall 10 |
|
Chu, Xiaobing |
Multi-omics integrated analysis revealed the key role of Fusobacterium periodonticum in colorectal tumorigenesis by decanoic acid-promoting neutrophil chemotaxis |
OS019 |
1-Hour Oral |
13:30-14:30 |
Hall 12 |
|
Fourati, Slim |
Virological characterisation of RSV after nirsevimab breakthrough infections in a multicentre observational real-world study in France |
OS032 |
2-Hour Oral |
16:15-18:15 |
Hall 14 |
|
Tan, Janice Yu Jin |
Impact of reinfection on post-acute sequelae of COVID-19 over multi-organ systems |
OS032 |
2-Hour Oral |
16:15-18:15 |
Hall 14 |
|
Gupta, Ruchika |
Vancomycin dependent Enterococci: an evolutionary dead end or the ultimate evolution of a superbug |
OS017 |
1-Hour Oral |
13:30-14:30 |
Hall 5 |
|
Bantuchai, Sirasate |
Influence of second blood meals on Plasmodium vivax development and infectivity in mosquitoes |
OS008 |
1-Hour Oral |
11:00-12:00 |
Hall 7 |
|
Krajcar, Nina |
Antibiotic-refractory oligoarthritis in an adolescent caused by Borrelia bavariensis in Croatia |
OS009 |
1-Hour Oral |
11:00-12:00 |
Hall 8 |
|
Bratković, Stanislava |
Clinical and economic burden of respiratory syncytial virus in adults with acute respiratory infections: a Danish nationwide cohort study |
OS032 |
2-Hour Oral |
16:15-18:15 |
Hall 14 |
|
Presenter |
Abstract Title |
Presentation |
Session Type |
Time |
Hall |
|---|---|---|---|---|---|
|
Paukner, Susanne |
In vitro activity and in vivo proof-of-efficacy of epimutilin derivatives AR-7732, AR-7731, AR-9842 and AR-10058 against R bacterial pathogens |
EF065 |
ePoster Flash |
16:15-17:15 |
Arena 1 |
|
Sánchez-Peña, Lucía |
Broad spectrum coverage of serine beta-lactase and high in vitro potency against KPC- and OXA-48-like-producing Enterobacterales of meropenem in combination with the novel diazabyciccloctane beta-lactase inhibitor ANT3310 |
EF065 |
ePoster Flash |
16:15-17:15 |
Arena 1 |
|
Sharomi, Oluwaseun |
Evaluating the impact of re-vaccination on pneumococcal disease in individuals previously vaccinated with PPSV23 in Germany: comparative approach |
EF066 |
ePoster Flash |
16:15-17:15 |
Arena 2 |
|
Zayyad, Hiba |
Is there a solution for hospital acquired infections due to the aquatic reservoir in the near patient environment? |
EF0398 |
ePoster Flash |
13:30-14:30 |
Arena 3 |
|
Forster, Johannes |
Blood culture volume, guideline adherence and pathogen yield of 35,433 paediatric blood cultures in Germany |
OS063 |
1-Hour Oral |
16:15-17:15 |
Hall 11 |
|
Moore, Andrew |
A consensus immune dysregulation frework for sepsis: results of the SUBSPACE consortium |
OS062 |
2-Hour Oral |
16:15-18:15 |
Hall 13 |
|
López-Cruz, Ian |
DNA methylation changes in sepsis: potential use as biomarkers |
OS062 |
2-Hour Oral |
16:15-18:15 |
Hall 13 |
|
Geurtsvankessel, Corine |
Why does rabies virus not induce an anti-viral immune response: insights from experimental models and a human cohort |
OS064 |
1-Hour Oral16:15-17:15 |
Hall 16 |
|
|
Maximova, Natalia |
Clinical outcomes of adoptive cell therapy for EBV reactivation and EBV-PTLD in primary immunodeficiencies: prophylactic and therapeutic applications of post-allo-HSCT memory T cell infusions |
OS073 |
1-Hour Oral |
17:30-18:30 |
Hall 16 |
|
Xu, Justin |
Predicting potentially infection-related findings in structured radiology reports |
OS052 |
1-Hour Oral |
13:30-14:30 |
Hall 2 |
|
Jiang, Chongyang |
Capsule-dependent modulation of cell death pathways and immune evasion in Acinetobacter baumannii |
OS053 |
1-Hour Oral |
13:30-14:30 |
Hall 3 |
|
Ekwem, Doris |
Atypical neonatal cutaneous myiasis: a diagnostic challenge mimicking pustular rash in a resource-limited setting |
OS044 |
1-Hour Oral |
11:00-12:00 |
Hall 5 |
|
Martinón-Torres, Federico |
Public health impact of universal prophylaxis with nirsevimab for prevention of infant hospitalisations due to respiratory syncytial virus: full 2023-24 season analysis of the NIRSE-GAL study (www.nirsegal.es/en) |
OS046 |
1-Hour Oral |
11:00-12:00 |
Hall 9 |
|
Presenter |
Abstract Title |
Presentation |
Session Type |
Time |
Hall |
|---|---|---|---|---|---|
|
Gould,Susan |
Air and surface spling around mpox Clade 1b in hospitals in the UK |
EF099 |
ePoster Flash |
14:45-15:45 |
Arena 1 |
|
Li, Bowen |
Acceleration of emergence of cefiderocol resistance in microfluidic evolution system |
EF100 |
ePoster Flash |
14:45-15:45 |
Arena 2 |
|
Coussement, Julien |
Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand |
EF081 |
ePoster Flash |
9:30-10:30 |
Arena 2 |
|
Sandoe, Jonathan |
Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record to assess safety, de-labelling and antibiotic prescribing: the ALABA randomised controlled trial |
EF106 |
ePoster Flash |
16:15-17:15 |
Arena 3 |
|
Muller, Beat Peter |
Diagnostic accuracy of a bacterial versus viral host-protein test for pediatric inpatients with acute infection |
OS086 |
1-Hour Oral |
11:00-12:00 |
Hall 11 |
|
Havlicek,Vladimir |
Diagnostic accuracy of combined urine lipocalin 2 and copper test in acute pyelonephritis or cystitis |
OS086 |
1-Hour Oral |
11:00-12:00 |
Hall 11 |
|
Wang,Hongyu |
Natural history of latent brucellosis and efficacy evaluation of B-spot in active and latent cases: a 12-month prospective cohort study |
OS097 |
1-Hour Oral |
14:45-15:45 |
Hall 14 |
|
P Freire, Maristela |
Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy |
OS088 |
1-Hour Oral |
11:00-12:00 |
Hall 16 |
|
Haggenburg, Sabine |
Long-term immunogenicity and biostability of the five-dose pneumococcal vaccination schedule following allogeneic haematopoietic stem cell transplantation: a prospective cohort study |
OS088 |
1-Hour Oral |
11:00-12:00 |
Hall 16 |
|
Ong, Sean |
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory posthoc analysis of the BALANCE randomised clinical trial |
OS082 |
1-Hour Oral |
11:00-12:00 |
Hall 2 |
|
Macesic, Nenad |
Bloodstream infection pathogen diversity and clinical impact revealed through unbiased whole genome sequencing: a prospective genomic epidemiology study |
OS082 |
1-Hour Oral |
11:00-12:00 |
Hall 2 |
|
Karssen, Dian |
Serotype distribution of pneumococcal community-acquired pneumonia in hospitalised adults in Germany |
OS095 |
1-Hour Oral |
14:45-15:45 |
Hall 2 |
|
Szabo,Balint Gergely |
The dark side of the „fifth disease” endemic: human parvovirus B19 infections transmitted through blood transfusions in adults with malignant haematological diseases |
OS083 |
1-Hour Oral |
11:00-12:00 |
Hall 5 |
|
Sanz De Mena, Manuela |
Clinical and microbiological impact of antibiotic-impregnated catheters in ventriculoperitoneal shunt infections in adults |
OS108 |
1-Hour Oral |
17:30-18:30 |
Hall 5 |
|
Hasivirwe Vakaniaki, Emmanuel |
Vertical transmission of Clade Ib monkeypoxvirus during pregnancy: clinical and histopathological description of three cases |
OS084 |
1-Hour Oral |
11:00-12:00 |
Hall 8 |
|
Pérez-Hernández, Isabel Ascensión |
First case of oropouche fever in the south of Spain |
OS084 |
1-Hour Oral |
11:00-12:00 |
Hall 8 |
|
Presenter |
Abstract Title |
Presentation |
Session Type |
Time |
Hall |
|---|---|---|---|---|---|
|
Bruss, Jon |
Evaluation of CRS3123 compared to vancomycin for the treatment of Clostridioides difficile infection (CDI) |
EF123 |
ePoster Flash |
11:00-12:00 |
Arena 2 |
|
Gao, Wenzhi |
Targeted NGS: a promising approach for pathogen detection of urinary tract infection |
EF124 |
ePoster Flash |
11:00-12:00 |
Arena 3 |
|
Caponcello, Maria Giulia |
ORCHESTRA delphi consensus: therapeutic and diagnostic management of SARS-CoV-2 infection in rheumatological patients |
EF133 |
ePoster Flash |
13:30-14:30 |
Arena 3 |
|
Molina Panadero, Irene |
A novel antibiotic class targeting the enolase of Acinetobacter baumannii |
OS113 |
2-Hour Oral |
8:30-10:30 |
Hall 11 |
|
Paul, Vivek Daniel |
A novel klebicin cocktail to treat lung infection caused by Klebsiella pneumoniae |
OS113 |
2-Hour Oral |
8:30-10:30 |
Hall 11 |
|
Brosius,Isabel |
Epidemiological and clinical features of mpox during the clade Ib outbreak in South-Kivu, Democratic Republic of the Congo: a prospective cohort study |
OS126 |
2-Hour Oral |
13:30-15:30 |
Hall 8 |
|
Vasikasin, Vasin |
Prospective evaluation of a machine learning-based real-time multidrug-resistant organism prediction system |
OS121 |
1-Hour Oral |
11:00-12:00 |
Hall 9 |
|
Presenter |
Intervention Code |
Abstract Title |
Category |
|---|---|---|---|
|
Baba, Keiko |
P0408 |
Phenotyping and genotyping analysis using baseline swab samples in ensitrelvir clinical studies |
Cat 1 |
|
Kerdiles, Thibault |
P0530 |
Higher SARS-CoV-2 viral load and delayed viral clearance in patients with autoantibodies neutralizing type I interferons |
Cat 1 |
|
Winkler, Marisa |
P2889 |
Echinocandin susceptibility patterns and genetic changes in nonsusceptible Candida glabrata with non-hotspot FKS alterations |
Cat 6 |
|
Meijer, Eelco F.J. |
P2955 |
SCY-247, a novel second-generation IV/oral triterpenoid antifungal, demonstrates in vitro activity against C. auris including the majority of strains exhibiting high MICs for echinocandins |
Cat 6 |
|
Presenter |
Intervention Code |
Abstract Title |
Category |
|---|---|---|---|
|
Pfäfflin, Frieder |
P0598 |
Mycobacterium chelonae infective endocarditis: data from the MYBACH registry |
Cat 2 |
|
Lamas, Cristiane |
P0778 |
A multicentre international study on Staphylococcus lugdunensis infective endocarditis |
Cat 2 |
|
Szojka, Zsófia I. |
P0913 |
Monitoring genomic evolution of Bordetella pertussis patient isolates in Austria before and after the COVID-19 pandemic |
Cat 2 |
|
Ruffin, Felicia |
P0819 |
Symptom duration and outcomes among patients with Staphylococcus aureus bloodstream infections |
Cat 2 |
|
Wen, Wang |
P2316 |
Benzoxaborole leucyl-tRNA synthetase inhibitor MRX-5: preclinical pharmacokinetics and in vitro drug-drug interaction |
Cat 5 |
|
Jamus, Andzoa |
P3667 |
Immunisation against Chlamydia trachomatis polymorphic membrane protein D tetrapeptide motifs limits early female reproductive tract infection in a mouse model |
Cat 11 |
|
Presenter |
Intervention Code |
Abstract Title |
Category |
|---|---|---|---|
|
Estabrook, Mark |
P1451 |
In vitro activities of aztreonam/nacubactam and cefepime/nacubactam against carbapenemase-producing Enterobacterales collected as part of a global surveillance study in 2021-2022 |
Cat 3 |
|
Echegorry, Mariano Paulo |
P1459 |
Standardising aztreonam/relebactam disk diffusion susceptibility testing in Enterobacterales: a step towards reliable clinical application |
Cat 3 |
|
Murillo-Torres, Marina |
P1848 |
Occurrence of carbapenemase resistance genes and proteins in Klebsiella pneumoniae extracellular membrane vesicles |
Cat 3 |
|
Le Terrier, Christophe |
P1631 |
The emerging concern of IMP variants being resistant to the only IMP-type metallo-beta-lactamase inhibitor, xeruborbactam |
Cat 3 |
|
Zhong, Yang |
P1869 |
Negative correlation between bloodstream iron acquisition virulence factors and non-classical terminal class 1 integrons in ESBL-producing Escherichia coli suggests potential fitness trade-offs between virulence and resistance |
Cat 3 |
|
Polani, Riccardo |
P1672 |
Engineered conjugative vectors as vehicles to study resistance and virulence in Klebsiella pneumoniae |
Cat 3 |
|
Naas, Thierry |
P1673 |
Role of S155, D159 and R214 amino-acid residues in the active site of OXA-48 variants |
Cat 3 |
|
Carloni, Sara |
P1720 |
Novel chromosomal target of cefiderocol resistance in Acinetobacter baumannii: a genomic and functional analysis to identify and validate in vivo acquired chemoresistance |
Cat 3 |
|
Sabatova, Katerina |
P2247 |
MethylomeMiner: a simple tool for processing and analysing DNA methylation data from sequencing |
Cat 4 |
|
Presenter |
Intervention Code |
Abstract Title |
Category |
|---|---|---|---|
|
Ong, Sean |
P3844 |
Sociodemographic characteristics of trial participants are under-reported in infectious diseases clinical trials: a systematic review |
Cat 12 |
|
Kim, Uh Jin |
P3903 |
Direct transmission of severe fever with thrombocytopenia syndrome virus (SFTS) from SFTS infected dog to human |
Cat 13 |